Natural Biocon (India) has informed that pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015 read with Schedule IV of the Companies Act, 2013, a separate meeting of the Independent Directors of the Company for the Financial Year 2024-25 was held today, on Friday, March 21, 2025 at the registered office of the company wherein the Independent Directors present at the meeting, transacted the following business: Reviewed the performance of non-independent directors and the board of directors as a whole; Reviewed the performance of the chairperson of the listed entity, taking into account the views of executive directors and non-executive directors; Assessed the quality, quantity and timeliness of flow of information between the management of the listed entity and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties.
The above information is a part of company’s filings submitted to BSE.